PFE.N
現在値
45.19USD変化
-0.49(-1.07%)出来高
7,944,253本日のレンジ
-
45.8052週レンジ
-
45.86∙ 約20分前の相場を表示しています。
Aug 3 (Reuters) - U.S. CDC::U.S. CDC SAYS DELIVERED 401,229,975 DOSES OF COVID-19 VACCINE AS OF AUG 3 VERSUS 400,674,965 DOSES DELIVERED AS OF AUG 2.U.S. CDC SAYS ADMINISTERED 347,377,149 DOSES OF COVID-19 VACCINE AS OF AUG 3 VERSUS 346,924,345 DOSES ADMINISTERED AS OF AUG 2.U.S. CDC SAYS 192,120,576 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF AUG 3 VERSUS 191,818,585 INDIVIDUALS AS OF AUG 2.U.S. CDC SAYS 165,081,416 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF AUG 3 VERSUS 164,919,666 INDIVIDUALS AS OF AUG 2. ((Reuters.Briefs@thomsonreuters.com;)).
Aug 2 (Reuters) - U.S. CDC::U.S. CDC SAYS DELIVERED 400,674,965 DOSES OF COVID-19 VACCINE AS OF AUG 2.U.S. CDC SAYS ADMINISTERED 346,924,345 DOSES OF COVID-19 VACCINE AS OF AUG 2 VERSUS 346,456,669 DOSES ADMINISTERED AS OF AUG 1.U.S. CDC SAYS 191,818,585 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF AUG 2 VERSUS 191,498,983 INDIVIDUALS AS OF AUG 1.U.S. CDC SAYS 164,919,666 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF AUG 2 VERSUS 164,757,423 INDIVIDUALS AS OF AUG 1. ((Reuters.Briefs@thomsonreuters.com;)).
Aug 1 (Reuters) - BioNTech SE <22UAy.DE>::U.S. CDC SAYS DELIVERED 400,675,525 DOSES OF COVID-19 VACCINE AS OF JULY 31 VERSUS 399,090,105 DOSES DELIVERED AS OF JULY 30.U.S. CDC SAYS ADMINISTERED 345,640,466 DOSES OF COVID-19 VACCINE AS OF JULY 31 VERSUS 344,071,595 DOSES ADMINISTERED AS OF JULY 30.U.S. CDC SAYS 190,982,149 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JULY 31 VERSUS 190,509,183 INDIVIDUALS AS OF JULY 30.U.S. CDC SAYS 164,446,964 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JULY 31 VERSUS 164,184,080 INDIVIDUALS AS OF JULY 30.
July 30 (Reuters) - U.S. CDC::U.S. CDC SAYS DELIVERED 399,090,105 DOSES OF COVID-19 VACCINE AS OF JULY 30 VERSUS 397,464,625 DOSES DELIVERED AS OF JULY 29.U.S. CDC SAYS ADMINISTERED 344,928,514 DOSES OF COVID-19 VACCINE AS OF JULY 30 VERSUS 344,071,595 DOSES ADMINISTERED AS OF JULY 29.U.S. CDC SAYS 190,509,183 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JULY 30 VERSUS 189,945,907 INDIVIDUALS AS OF JULY 29.U.S. CDC SAYS 164,184,080 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JULY 30 VERSUS 163,868,916 INDIVIDUALS AS OF JULY 29. ((Reuters.Briefs@thomsonreuters.com;)).
July 30 (Reuters) - :FDA, UNDER PRESSURE, PLANS ‘SPRINT’ TO ACCELERATE REVIEW OF PFIZER’S COVID-19 VACCINE FOR FULL APPROVAL - STAT NEWS.
July 29 (Reuters) - U.S. CDC::U.S. CDC SAYS DELIVERED 397,464,625 DOSES OF COVID-19 VACCINE AS OF JULY 29 VERSUS 395,974,515 DOSES DELIVERED AS OF JULY 28.U.S. CDC SAYS ADMINISTERED 344,071,595 DOSES OF COVID-19 VACCINE AS OF JULY 29 VERSUS 343,361,524 DOSES ADMINISTERED AS OF JULY 28.U.S. CDC SAYS 189,945,907 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JULY 29 VERSUS 189,494,180 INDIVIDUALS AS OF JULY 28.U.S. CDC SAYS 163,868,916 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JULY 29 VERSUS 163,588,042 INDIVIDUALS AS OF JULY 28. ((Reuters.Briefs@thomsonreuters.com;)).
July 28 (Reuters) - U.S. CDC::U.S. CDC SAYS DELIVERED 395,974,515 DOSES OF COVID-19 VACCINE AS OF JULY 28 VERSUS 395,460,845 DOSES DELIVERED AS OF JULY 27.U.S. CDC SAYS ADMINISTERED 343,361,524 DOSES OF COVID-19 VACCINE AS OF JULY 28 VERSUS 342,607,540 DOSES ADMINISTERED AS OF JULY 27.U.S. CDC SAYS 189,494,180 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JULY 28 VERSUS 188,996,475 INDIVIDUALS AS OF JULY 27.U.S. CDC SAYS 163,588,042 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JULY 28 VERSUS 163,312,474 INDIVIDUALS AS OF JULY 27. ((Reuters.Briefs@thomsonreuters.com;)).
July 28 (Reuters) - Pfizer Inc <PFE.N>::PFIZER INC - ABOUT 1 BILLION COVID-19 VACCINE DOSES SHIPPED SINCE DECEMBER 2020.PFIZER INC - REAFFIRM PROJECTED REVENUE CAGR OF AT LEAST 6% AND DOUBLE DIGIT EPS GROWTH THROUGH 2025.PFIZER INC - FIH FOR MODRNA FLU VACCINE PROJECTED ABOUT Q3 2021.PFIZER INC - DELTA VARIANT VACCINE: FIRST BATCH MANUFACTURED; CLINICAL STUDIES PROJECTED TO BEGIN IN AUG.PFIZER INC - BOOSTER DOSE: ONGOING DISCUSSIONS WITH REGULATORY AGENCIES, POTENTIAL SUBMISSION OF EUA APPLICATION AS EARLY AS AUG.PFIZER INC - POST DOSE 3 TITERS VERSUS. THE DELTA VARIANT ARE >5-FOLD POST DOSE 2 TITERS IN 18-55 Y/O & >11-FOLD POST DOSE 2 TITERS IN 65-85 Y/O.Further company coverage: PFE.N. ((Reuters.Briefs@thomsonreuters.com;)).
July 28 (Reuters) - Pfizer Inc <PFE.N>::PFIZER REPORTS SECOND-QUARTER 2021 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $1.07.Q2 EARNINGS PER SHARE ESTIMATE $0.97 -- REFINITIV IBES DATA.SECOND-QUARTER 2021 REVENUES OF $19.0 BILLION, REFLECTING 86% OPERATIONAL GROWTH.RAISES FULL-YEAR 2021 GUIDANCE FOR REVENUES TO A RANGE OF $78.0 TO $80.0 BILLION.EXCLUDING BNT162B2, REVENUES GREW 10% OPERATIONALLY TO $11.1 BILLION IN QUARTER.10% OPERATIONAL GROWTH EXCLUDING BNT162B2 IN Q2 2021 BUILDS ON 6% OPERATIONAL GROWTH DELIVERED BY COMPARABLE BUSINESS IN SECOND-QUARTER 2020.Q2 REPORTED DILUTED EPS OF $0.98.RAISES FY 2021 GUIDANCE FOR ADJUSTED DILUTED EPS TO A RANGE OF $3.95 TO $4.05.NOW ANTICIPATES 2021 REVENUES OF ABOUT $33.5 BILLION FOR BNT162B2, , REFLECTING 2.1 BILLION DOSES EXPECTED TO BE DELIVERED IN 2021.100% EFFICACY OBSERVED IN PHASE 2B TRIAL OF RSV ADULT VACCINE CANDIDATE.QTRLY REVENUES $ 18,977 MILLION VERSUS $ 9,864 MILLION.Q2 REVENUE VIEW $18.74 BILLION -- REFINITIV IBES DATA.SEES FY 2021 ADJUSTED COST OF SALES AS A PERCENTAGE OF REVENUES 39.0% TO 40.0%.QTRLY BNT162B2 ALLIANCE REVENUES AND DIRECT SALES $7,838 MILLION.QTRLY WORLDWIDE PREVNAR 13/PREVENAR 13 REVENUE $1,241 MILLION VERSUS $ 1,116 MILLION REPORTED LAST YEAR.QTRLY WORLDWIDE IBRANCE REVENUE $1,404 MILLION VERSUS $ 1,349 MILLION REPORTED LAST YEAR.SEES FY 2021 ADJUSTED DILUTED EPS GUIDANCE EXCLUDING BNT162B2 OF $2.55 - $2.65.CURRENT 2021 FINANCIAL GUIDANCE DOES NOT REFLECT ANY SHARE REPURCHASES IN 2021.
July 27 (Reuters) - U.S. CDC::U.S. CDC SAYS DELIVERED 395,460,845 DOSES OF COVID-19 VACCINE AS OF JULY 27 VERSUS 394,949,575 DOSES DELIVERED AS OF JULY 26.U.S. CDC SAYS ADMINISTERED 342,607,540 DOSES OF COVID-19 VACCINE AS OF JULY 27 VERSUS 342,212,051 DOSES ADMINISTERED AS OF JULY 26.U.S. CDC SAYS 188,996,475 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JULY 27 VERSUS 188,729,282 INDIVIDUALS AS OF JULY 26.U.S. CDC SAYS 163,312,474 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JULY 27 VERSUS 163,173,366 INDIVIDUALS AS OF JULY 26. ((Reuters.Briefs@thomsonreuters.com;)).
金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。